1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Global Clinical Trials Market, By Type, By Phase, By Study Design, By Indication, By End User, By Company, By Region, Forecast & Opportunities, 2026

Global Clinical Trials Market, By Type, By Phase, By Study Design, By Indication, By End User, By Company, By Region, Forecast & Opportunities, 2026

  • May 2021
  • 113 pages
  • ID: 6067205
  • Format: PDF
  • TechSci Research


Table of Contents

Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026

Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years. The market is driven by the outbreak of tropical and infectious diseases such as COVID-19, which has led to extensive clinical trials around the world in order to find the suitable treatment and vaccine. The growing adoption of virtual clinical trials that allow to collect data ?ff????ntl? and safely from ??rt?????nt? without the requirement of traveling to the lab or hospital is also acting as a major growth driver for the global clinical trials market. Moreover, the growing prevalence of n?ur?l?g???l d??????? such as ??rk?n??n’?, ?lzh??m?r’s and d??r?????n, coupled with growing geriatric population are some other key factors creating the need for clinical trials. Also, the digitization of clinical trials is anticipated to propel the growth of this market in the coming years.
Additionally, the increasing prevalence of chronic diseases and growing need for personalized drugs are some other key factors propelling the growth of the global clinical trials market.Governments in various economies are also providing favorable support for clinical trials in order to find the cure for deadly diseases like coronavirus.

The increasing expenditure on R&D activities and rise in biotechnology firms is also anticipated to drive the market growth through 2026.
Global clinical trials market can be segmented based on type, phase, study design, indication, end user and region.Based on indication, the market can be segmented into autoimmune/inflammation, oncology, CNS, diabetes, cardiovascular and others.

Among these, the oncology segment dominated the market until 2020 and is expected to maintain its dominance during the forecast period as well owing to increasing expenditure by the medical industry towards preclinical and clinical development of oncology drugs.
Regionally, Asia Pacific is anticipated to witness the fastest CAGR through 2026 owing to a large patient pool suffering from coronavirus and increasing number of biotechnology firms undergoing COVID-19 trials. The favorable support by governments in countries such as India and South Korea is also leading to extensive clinical trials in the two countries.
Major companies operating in the global clinical trials market include ?l? L?ll? ?nd ??m??n?, ?un ?h?rm???ut???l ?ndu?tr??? Ltd., N?v? N?rd??k ?/?, ?f?z?r ?n?., GlaxoSmithKline plc, ???N ?l?, Pharmaceutical Product Development Inc., F. ??ffm?nn-L? R??h? AG, ?QV?? ??ld?ng? ?n?., Covance Inc., Syneos Health Inc., PRA Health Sciences Inc., Medpace Holdings, Inc., WuXi Apptec Company Ltd., Thermo Fisher Scientific Inc., among others. The market players are undertaking growth strategies such as mergers and acquisitions along with new product launches to increase their share in the global clinical trials market.

Years considered for this report:

Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022-2026

Objective of the Study:

• To analyze the historical growth in the market size of the global clinical trials market from 2016 to 2020.
• To estimate and forecast the global clinical trials market from 2021 to 2026 and growth rate until 2026.
• To forecast the global clinical trials market based on type, phase, study design, indication, end user, company and regional distribution.
• To identify drivers and challenges for the global clinical trials market.
• To examine competitive developments such as expansions, new product launches, mergers and acquisitions, etc. in the global clinical trials market.
• To identify and analyze the profile of leading players operating in the global clinical trials market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of CROs across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the companies which could not be identified due to the limitations of secondary research.
The analyst calculated global clinical trials market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by the analyst.

Key Target Audience:

• Clinical trial research organisations, companies/partners and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, industry associations, forums and alliances related to clinical trials
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as clinical trials service provider companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, the global clinical trials market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Global Clinical Trials Market, By Type:
o Pharmaceutical Trials
o Medical Device Trials
• Global Clinical Trials Market, By Phase:
o Phase I
o Phase II
o Phase III
o Phase IV
• Global Clinical Trials Market, By Study Design:
o Interventional
o Observational
o Expanded Access
• Global Clinical Trials Market, By Indication:
o Autoimmune
o Oncology
o Diabetes
o Cardiovascular
o Others
• Global Clinical Trials Market, By End User:
o Clinical Research Organizations
o Pharmaceutical and Biotechnological Companies
o Clinical Testing Laboratories
o Others
• Global Clinical Trials Market, By Region:
o North America
United States
o Europe
United Kingdom
o Asia-Pacific
South Korea
o South America
o Middle East & Africa
South Africa
Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global clinical trials market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).
Profit Margin Analysis
• Profit margin analysis in case of direct and indirect sales channel.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on